Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

On behalf of the STOPDAPT-2 investigators, Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, Masahiro Natsuaki, Hiroki Shiomi, Toshiaki Toyota, Masanobu Ohya, Satoru Suwa, Kensuke Takagi, Mamoru Nanasato, Yoshiki Hata, Masahiro Yagi, Nobuhiro Suematsu, Takafumi Yokomatsu, Itaru Takamisawa, Masayuki Doi, Toshiyuki Noda, Hideki Okayama, Yoshitane Seino, Tomohisa Tada, Hiroki Sakamoto, Kiyoshi Hibi, Mitsuru Abe, Kazuya Kawai, Kōichi Nakao, Kenji Andò, Kengo Tanabe, Yuji Ikari, Keiichi Igarashi Hanaoka, Yoshihiro Morino, Ken Kozuma, Kazushige Kadota, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura